Home / Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics, Inc. (ACRS) Technical Analysis

Updated: 2026-03-17 00:39 UTC · Last close: 3.74 (+5.65%)
Aclaris Therapeutics, Inc. (ACRS) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Support
3.27
Resistance
Aclaris Therapeutics, Inc. (ACRS) closed at 3.74 (+5.65%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is notably strong at +17.24%, with price is trading in the upper part of its roughly 52-week range (1.08–4.53), while ATR14 volatility is elevated at roughly 7.27% of price. RSI(14) is 61.6, which keeps short-term momentum constructive without being overly stretched. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. From a pattern perspective, the main active signal is Cup & handle. Initial downside support sits near 3.27. Holding that area would help preserve the current chart structure. Latest fundamentals snapshot: Revenue: 1.12M · Net income: -64.92M · EPS (basic): -0.53. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
Fundamentals Snapshot
Source: sec
Company
Aclaris Therapeutics, Inc.
CIK (SEC ID)
0001557746
Shares Out.
120.50M
Revenue
1.12M
Net Income
-64.92M
EPS (Basic)
-0.53
Explore more
Shopify (SHOP) technical analysisBooking Holdings (BKNG) technical analysisBoeing Co (BA) technical analysisCaterpillar (CAT) technical analysisGeneral Electric Company (GE) technical analysisGoldman Sachs Group (GS) technical analysisWalmart (WMT) technical analysis
WOI OPEN FULL INTERACTIVE ANALYSIS
Note: This is an algorithmic technical snapshot (not financial advice).
ACRS Chart